24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publication dates

Gene Therapy Industry, December 2014 Market Reports from Top Publishers

You might be interested in: Medical Equipment, Cancer, Therapeutics, more »


 
1-10 of 34 reports for Gene Therapy

Gene Therapy Partnering Terms and Agreements

Gene Therapy Partnering Terms and Agreements

  • $ 1 995
  • Industry report
  • December 2014
  • by Currentpartnering

The Gene Therapy Partnering Agreements report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in ...

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2014

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

... therapy to activate rpgr for x-linked retinitis pigmentosa - drug profile 69product description 69mechanism of action 69r&d progress 69gene therapy to activate rpgr for x-linked retinitis ...

Critical Limb Ischemia - Pipeline Review, H2 2014

Critical Limb Ischemia - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

... R&d progress 59gene therapy to activate vascular endothelial growth factor for cardiovascular diseases - drug profile 60product description 60mechanism of action 60r&d progress 60 ...

MolMed S.p.A. (Symbol:MLM) SWOT Analysis, Strategy, Revenues and Profits

MolMed S.p.A. (Symbol:MLM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... In the fields of regenerative medicine and gene therapy. The company provides therapies for autologous and heterologous transplants. Molmed is headquartered in milano, italy.Molmed s.P.A. Key recent ...

Protokinetix Inc. (Symbol:PKTX) SWOT Analysis, Strategy, Revenues and Profits

Protokinetix Inc. (Symbol:PKTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

ReGenX Biosciences, LLC SWOT Analysis, Strategy, Revenues and Profits

ReGenX Biosciences, LLC SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Associated viral vectors. The company offers product for metabolic, muscle, hematologic, ocular and neurodegenerative disorders. It develops products in the areas of gene therapy, gene modulation, protein ...

VITA 34 International AG (V3V) - Financial and Strategic SWOT Analysis Review

VITA 34 International AG (V3V) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... On umbilical cord blood, which is used in acquired hearing loss, early childhood brain damage, aplastic anemia, blood cancer, solid tumors, type 1 diabetes, and gene therapy for severe immune deficiency ...

Zeltia, S.A. (ZEL) - Financial and Strategic SWOT Analysis Review

Zeltia, S.A. (ZEL) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Zeltia, S.A. (Zeltia) is a pharmaceutical holding company. It operates through a group of companies in biopharmaceutical and chemical sectors. Under biopharmaceutical sector it discovers and develops ...

Bluebird bio, Inc. (BLUE) - Financial and Strategic SWOT Analysis Review

Bluebird bio, Inc. (BLUE) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... To the patient. The company has a strategic collaboration with celgene corporation to discover, develop and commercialize disease-altering gene therapy products in oncology. Genetix is headquartered in cambridge ...

Global miRNA Market 2015-2019

Global miRNA Market 2015-2019

  • $ 2 500
  • Industry report
  • November 2014
  • by Infiniti Research Limited

About miRNAs miRNAs are single-stranded, small, non-coding RNA molecules that regulate gene expression at the translation level. They play a vital role in research, diagnostics, and therapeutics to study ...

About 500 reports for Gene Therapy

Download Unlimited Documents from Trusted Public Sources

Takara Bio Annual Report 2014

  • January 2014
    38 pages
  • Japan  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.